Helvetica Chimica Acta ± Vol. 85 (2002)
3933
4
,5-Dihydro-2-methyl{1,2-dideoxy-4-O-(b-d-galactopyranosyl)-a-d-glucopyranoso}[2,1-d]oxazole (1). A
mixture of N-acetyllactosamine (500 mg, 1.32 mmol), Ac O (2.7 ml), and pyridine (1.3 ml) was stirred at r.t.
for 22 h. After diluting with CHCl , the resulting soln. was washed with H O, and sat. aq. NaHCO soln., dried
Na SO ), and evaporated: crude lactosamine peracetate that was used for the following experiment without
2
3
2
3
(
2
4
further purification. To a soln. of lactosamine peracetate (948 mg, 1.40mmol) in 1,2-dichloroethane (17 ml),
trimethylsilyl trifluoromethanesulfonate (0.3 ml, 1.66 mmol) was added dropwise, and the mixture was heated at
5
08 for 5 h. Me
3
N (0.6 ml) was added and the mixture stirred for 10 min. After diluting with CHCl
3
, the mixture
was washed with cold H
2
O, the org. layer dried (Na SO ) and evaporated, and the residue submitted to column
2
4
chromatography (Merck silica gel 60 (0.040 ± 0.063 mm), AcOEt/hexane 4 :1) 520 mg of 4,5-dihydro-2-
methyl{1,2-dideoxy-4-O-(2,3,4,6-tetra-O-acetyl-b-d-galactopyranosyl)-a-d-glucopyranoso}[2,1-d]oxazole (61%).
To a soln. of this oxazole derivative (498 mg, 0.81 mmol) in MeOH (50 ml) was added a solution of 0.5m
NaOMe in MeOH (1.0ml) at 0 8, and the mixture was stirred at r.t. for 1 h. After neutralizing the mixture with
1
Amberlite IR-120 H , the solvent was evaporated: 1 (quant.). White solid. H-NMR (D
2
O, 400 MHz): 2.07
O, 100 MHz): 13.1 (NC(Me)O); 61.3 (C(6));
1.8 (C(6')); 65.3 (C(2)); 68.7 (C(4')); 69.4 (C(5)); 71.0(C(3)); 71.1 (C(2 ')); 72.6 (C(3')); 75.4 (C(5')); 78.3
1
3
(
s, NC(Me)O); 6.10( d, J(1,2) 7.31, HÀC(1)). C-NMR (D
2
6
(
C(4)); 100.0 (C(1)); 104.8 (C(1')); 168.4 (NC(Me)O).
Methyl O-b-d-Galactopyranosyl-(1 ! 4)-O-2-acetamido-2-deoxy-b-d-glucopyranosyl(1 ! 4)-2-acetamido-
2
-deoxy-b-d-glucopyranoside (Gal(b1 ±4)GlcNAc(b1 ±4)GlcNAcb-OMe; 3a). Glycosyl donor 1 (48 mg,
0
.13 mmol) and methyl (N-acetyl-b-d-glucosamin)ide (2a; GlcNAcb-OMe; 92 mg, 0.39 mmol) were dissolved
in 150 ml of 0.05m citric buffer (pH 9.0). To this mixture, chitinase (Bacillus sp., 10wt.-% for 1) dissolved in 80 ml
of 0.01m citric buffer (pH 9.0) was added, and the mixture was stirred for 0.5 h at 308. Yields were determined by
taking aliquots of the sample and evaporation of the solvent prior to HPLC analysis. For final workup, the
mixture was treated with THF to inactivate the enzyme. To obtain samples for NMR spectral analysis, semi-
prep. HPLC was performed. The HPLC fraction containing the product was chromatographically homogeneous.
1
H-NMR (D
2
O, 400 MHz): 3.49 (s, MeO); 4.41 (d, J(1,2) 7.85, HÀC(1)); 4.44 (d, J(1'',2'') 8.14, HÀC(1''));
13
4
(
.58 (d, J(1',2') 7.48, HÀC(1')). C-NMR (D
2
O, 100 MHz): 58.0 (MeO); 80.2 (C(4)); 102.2 (C(1')); 102.7
C(1)); 103.7 (C(1'')). MALDI-TOF-MS: 601.3 ([M Na] ; calc. 600.6).
Methyl O-b-d-Galactopyranosyl-(1 ! 4)-O-2-acetamido-2-deoxy-b-d-glucopyranosyl-(1 ! 4)-2-acetamido-
2
-deoxy-1-thio-b-d-glucopyranoside (Gal(b1 ± 4)GlcNAc(b1 ± 4)GlcNAcb-SMe; 3b. To 1 (18.5 mg, 0.05 mmol)
in a microtube was added a soln. of methyl 2-acetamido-2-deoxy-1-thio-b-d-glucopyranoside (2b) in 0.5 ml of
.05m carbonate buffer (pH 9.0), and the resulting mixture was incubated at 408. After adding an excess of THF,
0
the mixture was heated at 908 for 20min to deactivate the enzyme. The solvent was evaporated and the residue
1
dissolved in H
2
O and separated by prep. HPLC: 3b (13.0mg, 64%). H-NMR (D
2
O, 500 MHz): 2.01 (2 COMe);
2
.15 (s, MeS); 4.43 (d, J(1'',2'') 7.43, HÀC(1'')); 4.49 (d, J(1,2) 10.0, HÀC(1)); 4.56 (d, J(1',2') 7.89,
13
HÀC(1')). C-NMR (D
0.4 (C(6')); 61.2 (C(6'')); 68.7 (C(4'')); 71.1 (C(2'')); 72.3 (C(3)); 72.6 (C(3'')); 73.9 (C(3')); 75.0(C(5 ')); 75.5
C(5'')); 78.3 (C(5)); 78.6 (C(4')); 79.3 (C(4)); 84.7 (C(1)); 101.5 (C(1')); 103.0 (C(1'')); 174.6, 174.7 (2 COMe).
Trisaccharide Gal(b1 ± 4)GlcNAc(b1 ± 4)GlcNAcb-SCH CH CONHCH (3c). To 1
2
O, 125 MHz): 12.1 (MeS); 22.3 (2 NC(Me
3
)O); 53.9 (C(2)); 55.3 (C(2')); 60.0 (C(6));
6
(
2
2
2
NHCOCHCH
2
(
(
73 mg, 0.2 mmol) in a microtube was added a soln. of GlcNAc derivative 2c (26 mg, 66.7 mmol) and chitinase
Bacillus sp.; 7.3 mg, 292 mU) in 2.0 ml of 0.05m Tris buffer (pH 9.0), and the resulting mixture was incubated in
a dry thermo bath at 408. After adding an excess of THF, the mixture was heated at 908 for 20min to deactivate
the enzyme, and the solvent was evaporated. The residue was dissolved in H
2
O and separated by prep. HPLC
1
(
Inertsil-ODS, H
.54, 2.9 (m, SCH
0.0, HÀC(1)); 4.60( s, NCH
6.4, 36.0(SCH CH ); 44.4 (NCH
2
O/MeOH, 3.0ml/min): 3c (35 mg, 69%). H-NMR (D
2
O, 500 MHz): 1.96, 2.02 (s, 2 COMe);
2
1
2
2
CH
2
); 4.41 (d, J(1'',2'') 7.82, HÀC(1'')); 4.53 (d, J(1',2') 7.14, HÀC(1')); 4.56 (d, J(1,2)
13
2
N); 5.79 ± 6.19 (m, CHCH
2
). C-NMR (D
2
O, 125 MHz): 22.3 (2 NC(Me)O);
2
2
2
N); 54.2 (C(2)); 55.3 (C(2')); 60.0 (C(6')); 60.5 (C(6')); 61.2 (C(6'')); 68.7
(C(4'')); 71.1 (C(2'')); 72.2 (C(3')); 72.6 (C(3'')); 73.8 (C(3)); 74.9 (C(5')); 75.5 (C(5'')); 78.3 (C(4')); 78.5 (C(5));
7
1
9.4 (C(4)); 84.6 (C(1)); 101.5 (C(1')); 103.0 (C(1'')); 128.4 (CH
2
); 129.7 (CH); 168.8 (NHCOCH); 174.5 ±
74.8 (2 COMe). MALDI-TOF-MS: 778.8 ([M Na] ; calc. 779.9).
Tetrasaccharide Gal(b1 ± 4)GlcNAc(b1 ± 4)GlcNAc(b1 ± 4)GlcNAcb-SCH
2
CH
2
CONHCH
2
NHCOCHCH
2
(
5c). To 1 (18 mg, 48 mmol) in a microtube was added a solution of GlcNAc derivative 4c (19 mg, 32 mmol) and
chitinase (Bacillus sp., 70.4 mU) in 2.0 ml of 0.05m carbonate buffer (pH 10.4), and the resulting mixture was
incubated at 408 for 2 h. The mixture was heated at 908 for 20min to deactivate the enzyme, and the solvent was
evaporated. The residue was dissolved in H
2
O and separated by prep. HPLC (Inertsil-ODS, H
O, 400 MHz): 1.90 ± 1.96 (s, 3 COMe); 2.48, 2.83 (m, SCH
N); 5.68 ± 6.15
2
O/MeOH 900 :7,
1
5
4
.0ml/min): 5c (17 mg, 54%). H-NMR (D
.35 (d, J(1''',2''') 7.76); 4.45 ± 4.51 (HÀC(1), HÀC(1'), HÀC(1'')); 4.55 (s, NCH
2
2
CH );
2
2